Product image of Imigran Sprint (Sumatriptan) supplied by GNH India

Imigran Sprint

Active Ingredient:
Sumatriptan
Origin:
EU

Imigran Sprint (Sumatriptan)

Sumatriptan, the active ingredient in Imigran Sprint, is a Triptan presented as a 100 mg orally disintegrating tablet for oral use. It is indicated for the acute treatment of migraine attacks, with or without aura, in adult patients.

GNH India supplies Imigran Sprint as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets. The product is manufactured to European Union standards and distributed under strict quality controls. It meets all applicable pharmacopoeial specifications for safety and efficacy.

Manufacturer / TM Owner

Glaxosmithkline Pharma A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Sumatriptan is a selective serotonin 5‑HT1 receptor agonist used in the acute management of migraine.
  • Migraine with aura: rapid relief of headache and associated neurological symptoms.
  • Migraine without aura: reduction of headache intensity and duration.
  • Acute migraine attacks (any type): abortive treatment to alleviate pain and associated nausea.

How It Works

  • Sumatriptan selectively binds to 5‑HT1B and 5‑HT1D receptors on intracranial blood vessels and sensory nerve endings. Activation of 5‑HT1B receptors causes cranial vasoconstriction, while 5‑HT1D activation inhibits release of pro‑inflammatory neuropeptides such as CGRP, reducing neurogenic inflammation and pain transmission during a migraine attack.

Side Effects

Common Side Effects

  • Tingling or numbness in the face, fingers, or toes.
  • Chest discomfort or tightness.
  • Dizziness or light‑headedness.
  • Nausea or abdominal pain.
  • Dry mouth.
  • Fatigue.

Serious or Rare Side Effects

  • Coronary vasospasm leading to chest pain or myocardial ischemia.
  • Severe hypertension or hypertensive crisis.
  • Serotonin syndrome, especially with serotonergic agents.
  • Allergic reactions such as rash, angioedema, or anaphylaxis.
  • Cardiac arrhythmias.
  • Stroke or transient ischemic attack.

Precautions & Warnings

  • Before prescribing, evaluate cardiovascular risk and contraindications.
  • Assess cardiovascular history: avoid use in patients with ischemic heart disease or uncontrolled hypertension.
  • Avoid concomitant ergotamine: increased risk of vasospasm.
  • Use caution in patients with severe hepatic impairment.
  • Do not exceed the recommended dose frequency as directed by the prescriber.
  • Avoid in patients with known hypersensitivity to sumatriptan or any tablet excipients.
  • Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Sumatriptan may interact with several drug classes; monitoring is essential.

Major Interactions (Avoid)

  • MAO inhibitors: risk of serotonin syndrome.
  • Ergot derivatives: additive vasoconstrictive effects.
  • Other triptans: cumulative serotonergic activity.

Moderate Interactions (Monitor Closely)

  • SSRIs or SNRIs: potential for serotonin syndrome.
  • Beta‑blockers: may increase plasma concentrations of sumatriptan.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): elevate exposure and side‑effect risk.

Frequently Asked Questions

Imigran Sprint contains sumatriptan, a Triptan indicated for the acute treatment of migraine attacks, with or without aura, in adult patients. It is taken at the onset of migraine symptoms to relieve headache and associated features such as nausea, photophobia, and phonophobia.

Sumatriptan acts as a selective agonist at serotonin 5‑HT1B and 5‑HT1D receptors. Stimulation of 5‑HT1B receptors produces cranial vasoconstriction, while activation of 5‑HT1D receptors inhibits release of inflammatory neuropeptides, reducing neurogenic inflammation and interrupting pain transmission during a migraine episode.

The prescribed dose of Imigran Sprint is determined by a qualified healthcare professional based on individual patient needs and clinical response. The prescriber will decide the appropriate amount and frequency, which should not exceed the maximum recommended limits.

The safety of sumatriptan in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the prescribing clinician.

To request Imigran Sprint, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imigran Sprint (sumatriptan) belongs to the Triptan class, which specifically targets serotonin receptors to abort migraine attacks. Compared with non‑specific analgesics, triptans provide faster and more complete relief of migraine pain and associated symptoms, but they are contraindicated in certain cardiovascular conditions.

Imigran Sprint should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture and direct sunlight to maintain product stability throughout its shelf life.

Imigran Sprint is an orally disintegrating tablet that is placed on the tongue, where it dissolves rapidly without the need for water. The patient should allow the tablet to fully dissolve before swallowing any residual saliva.

Serious risks include coronary vasospasm, which can cause chest pain or myocardial ischemia, and serotonin syndrome, especially when combined with other serotonergic agents. Patients should be educated to seek immediate medical attention if they experience severe chest discomfort, rapid heartbeat, or signs of an allergic reaction.

Imigran Sprint is contraindicated in patients with a history of ischemic heart disease, uncontrolled hypertension, severe hepatic impairment, or known hypersensitivity to sumatriptan or any tablet component. It should also be avoided in individuals taking ergotamine-containing medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sumatriptan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT